User menu

Low-dose vs. high-dose thalidomide for advanced multiple myeloma: a prospective trial from the Intergroupe Francophone du Myélome.

Bibliographic reference Yakoub-Agha, Ibrahim ; Mary, Jean-Yves ; Hulin, Cyrille ; Doyen, Chantal ; Marit, Gérald ; et. al. Low-dose vs. high-dose thalidomide for advanced multiple myeloma: a prospective trial from the Intergroupe Francophone du Myélome.. In: European journal of haematology, Vol. 88, no.3, p. 249-59 (2012)
Permanent URL http://hdl.handle.net/2078.1/123497
  1. Facon Thierry, Mary Jean Yves, Hulin Cyrille, Benboubker Lotfi, Attal Michel, Pegourie Brigitte, Renaud Marc, Harousseau Jean Luc, Guillerm Gaëlle, Chaleteix Carine, Dib Mamoun, Voillat Laurent, Maisonneuve Hervé, Troncy Jacques, Dorvaux Véronique, Monconduit Mathieu, Martin Claude, Casassus Philippe, Jaubert Jérôme, Jardel Henry, Doyen Chantal, Kolb Brigitte, Anglaret Bruno, Grosbois Bernard, Yakoub-Agha Ibrahim, Mathiot Claire, Avet-Loiseau Hervé, Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99–06): a randomised trial, 10.1016/s0140-6736(07)61537-2
  2. Singhal Seema, Mehta Jayesh, Desikan Raman, Ayers Dan, Roberson Paula, Eddlemon Paul, Munshi Nikhil, Anaissie Elias, Wilson Carla, Dhodapkar Madhav, Zeldis Jerome, Siegel David, Crowley John, Barlogie Bart, Antitumor Activity of Thalidomide in Refractory Multiple Myeloma, 10.1056/nejm199911183412102
  3. Yakoub-Agha Ibrahim, Attal Michel, Dumontet Charles, Delannoy Válerie, Moreau Philippe, Berthou Christian, Lamy Thierney, Grosbois Bernard, Dauriac Charly, Dorvaux Véronique, Bay Jacques-Olivier, Monconduit Matthieu, Harousseau Jean Luc, Duguet Corinne, Duhamel Alain, Facon Thierry, Thalidomide in patients with advanced multiple myeloma: a study of 83 patients–report of the intergroupe francophone du myélome (IFM), 10.1038/sj.thj.6200175
  4. Barlogie B., Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients, 10.1182/blood.v98.2.492
  5. Palumbo A., Facon T., Sonneveld P., Blade J., Offidani M., Gay F., Moreau P., Waage A., Spencer A., Ludwig H., Boccadoro M., Harousseau J.-L., Thalidomide for treatment of multiple myeloma: 10 years later, 10.1182/blood-2007-10-117457
  6. Boccadoro Mario, Blade Joan, Attal Michel, Palumbo Antonio, The Future Role of Thalidomide in Multiple Myeloma, 10.1159/000087040
  7. Hussein Mohamad A, Thalidomide: present and future in multiple myeloma, 10.1586/14737140.5.1.25
  8. Isoardo G., Bergui M., Durelli L., Barbero P., Boccadoro M., Bertola A., Ciaramitaro P., Palumbo A., Bergamasco B., Cocito D., Thalidomide neuropathy: clinical, electrophysiological and neuroradiological features, 10.1034/j.1600-0404.2003.00203.x
  9. Laaksonen, Electromyogr Clin Neurophysiol, 45, 75 (2005)
  10. Plasmati R., Pastorelli F., Cavo M., Petracci E., Zamagni E., Tosi P., Cangini D., Tacchetti P., Salvi F., Bartolomei I., Michelucci R., Tassinari C. A., Neuropathy in multiple myeloma treated with thalidomide: A prospective study, 10.1212/01.wnl.0000267271.18475.fe
  11. Boccadoro M., Palumbo A., New developments and treatment in multiple myeloma: new drugs in the treatment of multiple myeloma, 10.1093/annonc/mdf639
  12. Dimopoulos M. A., Zervas K., Kouvatseas G., Galani E., Grigoraki V., Kiamouris Ch., Vervessou E., Samantas E., Papadimitriou Ch., Ecomomou O., Gika D., Panayiotidis P., Christakis I., Anagnostopoulos N., Thalidomide and dexamethasone combination for refractory multiple myeloma, 10.1023/a:1011132808904
  13. Juliusson Gunnar, Celsing Fredrik, Turesson Ingemar, Lenhoff Stig, Adriansson Magnus, Malm Claes, Frequent good partial remissions from thalidomide including best response ever in patients with advanced refractory and relapsed myeloma, 10.1046/j.1365-2141.2000.01983.x
  14. Durie Brian G.M., Low-dose thalidomide in myeloma: Efficacy and biologic significance, 10.1053/sonc.2002.34075
  15. Leleu X., Efficacy of a low dose of thalidomide in advanced multiple myeloma, 10.1182/blood-2002-05-1527
  16. Palumbo, Haematologica, 86, 399 (2001)
  17. Rajkumar S. Vincent, Hayman Suzanne, Gertz Morie A., Dispenzieri Angela, Lacy Martha Q., Greipp Philip R., Geyer Susan, Iturria Nancy, Fonseca Rafael, Lust John A., Kyle Robert A., Witzig Thomas E., Combination Therapy With Thalidomide Plus Dexamethasone for Newly Diagnosed Myeloma, 10.1200/jco.2002.02.116
  18. Mohty M, Attal M, Marit G, Bulabois C E, Garban F, Gratecos N, Rio B, Vernant J P, Sotto J J, Cahn J Y, Blaise D, Jouet J P, Facon T, Yakoub-Agha I, Thalidomide salvage therapy following allogeneic stem cell transplantation for multiple myeloma: a retrospective study from the Intergroupe Francophone du Myélome (IFM) and the Société Française de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC), 10.1038/sj.bmt.1704756
  19. Myers B., Grimley C., Dolan G., Thalidomide and low-dose dexamethasone in myeloma treatment, 10.1046/j.1365-2141.2001.02873-5.x
  20. Spencer Andrew, Prince H. Miles, Roberts Andrew W., Prosser Ian W., Bradstock Kenneth F., Coyle Luke, Gill Devinder S., Horvath Noemi, Reynolds John, Kennedy Nola, Consolidation Therapy With Low-Dose Thalidomide and Prednisolone Prolongs the Survival of Multiple Myeloma Patients Undergoing a Single Autologous Stem-Cell Transplantation Procedure, 10.1200/jco.2008.18.8573
  21. Anagnostopoulos Athanasios, Weber Donna, Rankin Kim, Delasalle Kay, Alexanian Raymond, Thalidomide and dexamethasone for resistant multiple myeloma, 10.1046/j.1365-2141.2003.04345.x
  22. Palumbo Antonio, Falco Patrizia, Ambrosini Maria Teresa, Petrucci Maria Teresa, Musto Pellegrino, Caravita Tommaso, Pregno Patrizia, Bertola Alessandra, Cavallo Federica, Ciccone Giovannino, Boccadoro Mario, Thalidomide plus dexamethasone is an effective salvage regimen for myeloma patients relapsing after autologous transplant, 10.1111/j.1600-0609.2005.00533.x
  23. Dimopoulos Meletios A, Hamilos George, Zomas Athanasios, Gika Dimitra, Efstathiou Eleni, Grigoraki Vassiliki, Poziopoulos Christos, Xilouri Irini, Zorzou Markela P, Anagnostopoulos Nikolaos, Anagnostopoulos Athanasios, Pulsed cyclophosphamide, thalidomide and dexamethasone: an oral regimen for previously treated patients with multiple myeloma, 10.1038/sj.thj.6200326
  24. Hussein M. A., Modifications to Therapy for Multiple Myeloma: Pegylated Liposomal Doxorubicin in Combination With Vincristine, Reduced-Dose Dexamethasone, and Thalidomide, 10.1634/theoncologist.8-suppl_3-39
  25. Kropff Martin H., Lang Nicola, Bisping Guido, Domine Nicole, Innig Georg, Hentrich Markus, Mitterer Manfred, Sudhoff Thomas, Fenk Roland, Straka Christian, Heinecke Achim, Koch Olaf M., Ostermann Helmut, Berdel Wolfgang E., Kienast Joachim, Hyperfractionated cyclophosphamide in combination with pulsed dexamethasone and thalidomide (HyperCDT) in primary refractory or relapsed multiple myeloma, 10.1046/j.1365-2141.2003.04473.x
  26. Moehler T. M., Salvage therapy for multiple myeloma with thalidomide and CED chemotherapy, 10.1182/blood.v98.13.3846
  27. Dimopoulos Meletios A, Anagnostopoulos Athanasios, Thalidomide in relapsed/refractory multiple myeloma: pivotal trials conducted outside the United States, 10.1053/j.seminhematol.2003.09.008
  28. Glasmacher Axel, von Lilienfeld-Toal Marie, The Current Status of Thalidomide in the Management of Multiple Myeloma, 10.1159/000087037
  29. Rajkumar S. Vincent, Blood Emily, Vesole David, Fonseca Rafael, Greipp Philip R., Phase III Clinical Trial of Thalidomide Plus Dexamethasone Compared With Dexamethasone Alone in Newly Diagnosed Multiple Myeloma: A Clinical Trial Coordinated by the Eastern Cooperative Oncology Group, 10.1200/jco.2005.03.0221
  30. Zangari M., Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy, 10.1182/blood.v98.5.1614
  31. Zangari Maurizio, Barlogie Bart, Anaissie Elias, Saghafifar Fariba, Eddlemon Paul, Jacobson Joth, Lee Choon-Kee, Thertulien Raymond, Talamo Giampaolo, Thomas Teri, Rhee Frits Van, Fassas Athanasios, Fink Louis, Tricot Guido, Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulation, 10.1111/j.1365-2141.2004.05078.x
  32. Berenson J R, Lichtenstein A, Porter L, Dimopoulos M A, Bordoni R, George S, Lipton A, Keller A, Ballester O, Kovacs M, Blacklock H, Bell R, Simeone J F, Reitsma D J, Heffernan M, Seaman J, Knight R D, Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group., 10.1200/jco.1998.16.2.593
  33. Anderson Kenneth C., Pazdur Richard, Farrell Ann T., Development of Effective New Treatments for Multiple Myeloma, 10.1200/jco.2005.02.4950
  34. Barlogie B., Treatment of multiple myeloma, 10.1182/blood-2003-04-1045
  35. Rajkumar S. V., Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma, 10.1182/blood-2005-07-2817
  36. Richardson Paul G, Mitsiades Constantine, Bortezomib: proteasome inhibition as an effective anticancer therapy, 10.1517/14796694.1.2.161
  37. Richardson, Oncology, 19, 1781 (2005)